by Elana Gotkine For adults with rheumatoid arthritis (RA), there is a modest reduction in the mean Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) at three months for patients receiving tofacitinib (TOF) versus adalimumab (ADA), but there is no difference at nine months, according to a study published online June 29 in JAMA...
Tag: <span>Tofacitinib</span>
Post
Tofacitinib shows promise in scleroderma patients, researchers optimistic for next phase of study
MICHIGAN MEDICINE – UNIVERSITY OF MICHIGAN Systemic sclerosis — or scleroderma that affects the skin and internal organs -, is one of the rarest autoimmune diseases, affecting roughly 100,000 people (primarily women) in the United States., However, systemic sclerosis is devastating—it has the highest mortality rate among rheumatic diseases, according to Dinesh Khanna M.B.B.S., M.Sc.,...
Post
Tofacitinib for severe ulcerative colitis: Will it prevent colectomies?
Acute severe ulcerative colitis, or ASUC, can be extremely debilitating. Symptoms for the condition range from frequent bloody bowel movements to anemia, weight loss, and even fevers and chills. And nearly 30% of individuals who develop an episode of ASUC require a colectomy, which is a surgery that involves removing parts, or all, of your...